A. Kosaka

发表

Molecular cloning, genomic characterization and expression of novel human α1A‐adrenoceptor isoforms

A. Ford, D. V. Daniels, R. Eglen, 1998 .

Expression of human dopamine beta-hydroxylase in Drosophila Schneider 2 cells.

A. Kosaka, C. Bach, H. Chan, 1996, The Biochemical journal.

Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia

Michael V. Gormally, J. Fung, A. Kosaka, 2015, eLife.

Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

J. Fung, A. Kosaka, Xiaochuan Shan, 2017, eLife.

Cloning, expression and pharmacology of a truncated splice variant of the human 5‐HT7 receptor (h5‐HT7(b))

R. Eglen, J. Jasper, D. Chang, 1997 .

Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

A. Kosaka, T. Cihlar, A. Ray, 2014, Kidney international.

A quantitative analysis of purinoceptor expression in human fetal and adult bladders.

A. Ford, S. McMahon, R. Popert, 2001, The Journal of urology.

Isoproterenol Acts as a Biased Agonist of the Alpha-1A-Adrenoceptor that Selectively Activates the MAPK/ERK Pathway

Paul J. Dietrich, A. Ford, M. Milla, 2015, PloS one.

P2X receptors and their role in female idiopathic detrusor instability.

G. Burnstock, A. Ford, S. McMahon, 2002, The Journal of urology.

Facilitatory Interplay in α1a and β2 Adrenoceptor Function Reveals a Non-Gq Signaling Mode: Implications for Diversification of Intracellular Signal Transduction

A. Ford, Helen Yu, M. Milla, 2009, Molecular Pharmacology.

Pharmacological and functional characterization of bradykinin B2 receptor in human prostate.

A. Ford, D. V. Daniels, D. Srinivasan, 2004, European journal of pharmacology.

Facilitatory Interplay in (cid:1) 1a and (cid:2) 2 Adrenoceptor Function Reveals a Non-G q Signaling Mode: Implications for Diversification of Intracellular Signal Transduction □ S

Helen Yu, M. Milla, A. Copik, 2009 .

Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients.

A. Kosaka, J. Symons, N. Cammack, 2008, The Journal of antimicrobial chemotherapy.

Distributed under Creative Commons Cc-by 4.0 Registered Report: Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer

J. Fung, E. Iorns, A. Kosaka, 2022 .

RG7128 alone or in combination with pegylated interferon-α2a and ribavirin prevents hepatitis C virus (HCV) Replication and selection of resistant variants in HCV-infected patients.

A. Kosaka, N. Cammack, S. Le Pogam, 2010, The Journal of infectious diseases.

Alone or in Combination with Pegylated Interferon-a 2 a and Ribavirin Prevents Hepatitis C Virus ( HCV ) Replication and Selection of Resistant Variants in HCV-Infected Patients

A. Kosaka, S. Pogam, N. Cammack, 2010 .

Characterization of Hepatitis C Virus (HCV) Quasispecies Dynamics upon Short-Term Dual Therapy with the HCV NS5B Nucleoside Polymerase Inhibitor Mericitabine and the NS3/4 Protease Inhibitor Danoprevir

A. Kosaka, D. Chin, S. Pogam, 2012, Antimicrobial Agents and Chemotherapy.

Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.

Andrej Sali, Natalia Khuri, A. Sali, 2013, Journal of medicinal chemistry.

21 LOW LEVEL OF RESISTANCE, LOW VIRAL FITNESS AND ABSENCE OF RESISTANCE MUTATIONS IN BASELINE QUASISPECIES MAY CONTRIBUTE TO HIGH BARRIER TO R1626 RESISTANCE IN VIVO

A. Kosaka, J. Symons, S. Pogam, 2008 .

958 NO EVIDENCE OF R7128 DRUG RESISTANCE AFTER UP TO 4 WEEKS TREATMENT OF GT 1, 2 AND 3 HEPATITIS C VIRUS INFECTED INDIVIDUALS

A. Kosaka, S. Pogam, I. Nájera, 2009 .

Cloning and Expression of a 5‐Hydroxytryptamine7 Receptor Positively Coupled to Adenylyl Cyclase

A. Tsou, R. Alvarez, R. Eglen, 1994, Journal of neurochemistry.

Assessment of the relationship between signal intensities and transcript concentration for Affymetrix GeneChip® arrays

E. Chudin, A. Kosaka, T. K. Chang, 2001, Genome Biology.

Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).

R. Eglen, J. Jasper, D. Chang, 1997, British journal of pharmacology.

A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic outlet obstruction

A. Ford, S. McMahon, R. Popert, 2001, BJU international.